Mapping of MN1 Sequences Necessary for Myeloid Transformation

PLoS ONE

Volumn 8, Issue 4, 2013, Pages

  Kandilci, Ayten ^a,b   Surtel, Jacqueline ^a   Janke, Laura ^a   Neale, Geoffrey ^a   Terranova, Sabrina ^a   Grosveld, Gerard C ^a  

^a ST JUDE CHILDREN S RESEARCH HOSPITAL   (United States)

^b GEBZE TECHNICAL UNIVERSITY   (Turkey)

Author keywords

[No Author keywords available]

Indexed keywords

CCAAT ENHANCER BINDING PROTEIN ALPHA; CCAAT ENHANCER BINDING PROTEIN BETA; CCAAT ENHANCER BINDING PROTEIN DELTA; PROTEIN MYB; TRANSCRIPTION FACTOR HOXA9; TRANSCRIPTION FACTOR RUNX2; MN1 PROTEIN, MOUSE; ONCOPROTEIN; TUMOR PROTEIN;

ANIMAL CELL; ANIMAL TISSUE; ANTIBODY DETECTION; ARTICLE; BIOTINYLATION; BONE MARROW CELL; CARCINOGENESIS; CELL DIFFERENTIATION; CELL LINEAGE; CELL PROLIFERATION; CELL RENEWAL; CONTROLLED STUDY; GENE EXPRESSION; GENE EXPRESSION PROFILING; GENE MAPPING; GENE SEQUENCE; GENETIC TRANSCRIPTION; GENETIC TRANSFORMATION; IN VITRO STUDY; MICROARRAY ANALYSIS; MN1 GENE; MOUSE; MYELOPROLIFERATIVE DISORDER; NONHUMAN; ONCOGENE; OPEN READING FRAME; PROTEIN PURIFICATION; SIGNAL TRANSDUCTION; ACUTE GRANULOCYTIC LEUKEMIA; AMINO ACID SEQUENCE; ANIMAL; CANCER STEM CELL; CELL COUNT; CELL TRANSFORMATION; GENE DELETION; GENE EXPRESSION REGULATION; GENE VECTOR; GENETIC TRANSDUCTION; GENETICS; HUMAN; METABOLISM; MOLECULAR GENETICS; MORTALITY; PATHOLOGY; RETROVIRUS; SURVIVAL;

AMINO ACID SEQUENCE; ANIMALS; BONE MARROW CELLS; CELL COUNT; CELL DIFFERENTIATION; CELL PROLIFERATION; CELL TRANSFORMATION, NEOPLASTIC; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION, NEOPLASTIC; GENETIC VECTORS; HUMANS; LEUKEMIA, MYELOID, ACUTE; MICE; MOLECULAR SEQUENCE DATA; MYELOID CELLS; NEOPLASM PROTEINS; NEOPLASTIC STEM CELLS; ONCOGENE PROTEINS; RETROVIRIDAE; SEQUENCE DELETION; SURVIVAL ANALYSIS; TRANSDUCTION, GENETIC;

EID: 84876527480     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0061706     Document Type: Article

References (29)

1. Rosenbauer F, Tenen DG, (2007) Transcription factors in myeloid development: balancing differentiation with transformation. Nat Rev Immunol 7: 105-117.
2. Gilliland DG, (2001) Hematologic malignancies. Curr Opin Hematol 8: 189-191.
3. Meester-Smoor MA, Vermeij M, van Helmond MJ, Molijn AC, van Wely KH, et al. (2005) Targeted disruption of the Mn1 oncogene results in severe defects in development of membranous bones of the cranial skeleton. Mol Cell Biol 25: 4229-4236.
4. Buijs A, Sherr S, van Baal S, van Bezouw S, van der Plas D, et al. (1995) Translocation (12;22) (p13;q11) in myeloproliferative disorders results in fusion of the ETS-like TEL gene on 12p13 to the MN1 gene on 22q11. Oncogene 10: 1511-1519.
5. Valk PJ, Verhaak RG, Beijen MA, Erpelinck CA, Barjesteh van Waalwijk van Doorn-Khosrovani S, et al. (2004) Prognostically useful gene-expression profiles in acute myeloid leukemia. N Engl J Med 350: 1617-1628.
6. Ross ME, Mahfouz R, Onciu M, Liu HC, Zhou X, et al. (2004) Gene expression profiling of pediatric acute myelogenous leukemia. Blood 104: 3679-3687.
7. Carella C, Bonten J, Sirma S, Kranenburg TA, Terranova S, et al. (2007) MN1 overexpression is an important step in the development of inv(16) AML. Leukemia 21: 1679-1690.
8. Baldus CD, Mrozek K, Marcucci G, Bloomfield CD, (2007) Clinical outcome of de novo acute myeloid leukaemia patients with normal cytogenetics is affected by molecular genetic alterations: a concise review. Br J Haematol 137: 387-400.
9. Heuser M, Beutel G, Krauter J, Dohner K, von Neuhoff N, et al. (2006) High meningioma 1 (MN1) expression as a predictor for poor outcome in acute myeloid leukemia with normal cytogenetics. Blood 108: 3898-3905.
10. Slape C, Hartung H, Lin YW, Bies J, Wolff L, et al. (2007) Retroviral insertional mutagenesis identifies genes that collaborate with NUP98-HOXD13 during leukemic transformation. Cancer Res 67: 5148-5155.
11. Liu T, Jankovic D, Brault L, Ehret S, Baty F, et al. (2010) Functional characterization of high levels of meningioma 1 as collaborating oncogene in acute leukemia. Leukemia 24: 601-612.
12. Heuser M, Argiropoulos B, Kuchenbauer F, Yung E, Piper J, et al. (2007) MN1 overexpression induces acute myeloid leukemia in mice and predicts ATRA resistance in patients with AML. Blood 110: 1639-1647.
13. Kandilci A, Grosveld GC, (2009) Reintroduction of CEBPA in MN1-overexpressing hematopoietic cells prevents their hyperproliferation and restores myeloid differentiation. Blood 114: 1596-1606.
14. Buijs A, van Rompaey L, Molijn AC, Davis JN, Vertegaal AC, et al. (2000) The MN1-TEL fusion protein, encoded by the translocation (12;22)(p13;q11) in myeloid leukemia, is a transcription factor with transforming activity. Mol Cell Biol 20: 9281-9293.
15. Boer J, Bonten-Surtel J, Grosveld G, (1998) Overexpression of the nucleoporin CAN/NUP214 induces growth arrest, nucleocytoplasmic transport defects, and apoptosis. Mol Cell Biol 18: 1236-1247.
16. Akashi K, Traver D, Miyamoto T, Weissman IL, (2000) A clonogenic common myeloid progenitor that gives rise to all myeloid lineages. Nature 404: 193-197.
17. Irizarry RA, Hobbs B, Collin F, Beazer-Barclay YD, Antonellis KJ, et al. (2003) Exploration, normalization, and summaries of high density oligonucleotide array probe level data. Biostatistics 4: 249-264.
18. Huang da W, Sherman BT, Lempicki RA, (2009) Systematic and integrative analysis of large gene lists using DAVID bioinformatics resources. Nat Protoc 4: 44-57.
19. Subramanian A, Tamayo P, Mootha VK, Mukherjee S, Ebert BL, et al. (2005) Gene set enrichment analysis: a knowledge-based approach for interpreting genome-wide expression profiles. Proc Natl Acad Sci U S A 102: 15545-15550.
20. Cardone M, Kandilci A, Carella C, Nilsson JA, Brennan JA, et al. (2005) The novel ETS factor TEL2 cooperates with Myc in B lymphomagenesis. Mol Cell Biol 25: 2395-2405.
21. Carella C, Bonten J, Rehg J, Grosveld GC, (2006) MN1-TEL, the product of the t(12;22) in human myeloid leukemia, immortalizes murine myeloid cells and causes myeloid malignancy in mice. Leukemia 20: 1582-1592.
22. Heuser M, Yun H, Berg T, Yung E, Argiropoulos B, et al. (2011) Cell of origin in AML: susceptibility to MN1-induced transformation is regulated by the MEIS1/AbdB-like HOX protein complex. Cancer cell 20: 39-52.
23. Hess JL, Bittner CB, Zeisig DT, Bach C, Fuchs U, et al. (2006) c-Myb is an essential downstream target for homeobox-mediated transformation of hematopoietic cells. Blood 108: 297-304.
24. Jin S, Zhao H, Yi Y, Nakata Y, Kalota A, et al. (2010) c-Myb binds MLL through menin in human leukemia cells and is an important driver of MLL-associated leukemogenesis. J Clin Invest 120: 593-606.
25. Slany RK, (2009) The molecular biology of mixed lineage leukemia. Haematologica 94: 984-993.
26. Kuo YH, Zaidi SK, Gornostaeva S, Komori T, Stein GS, et al. (2009) Runx2 induces acute myeloid leukemia in cooperation with Cbfbeta-SMMHC in mice. Blood 113: 3323-3332.
27. Zhang P, Iwasaki-Arai J, Iwasaki H, Fenyus ML, Dayaram T, et al. (2004) Enhancement of hematopoietic stem cell repopulating capacity and self-renewal in the absence of the transcription factor C/EBP alpha. Immunity 21: 853-863.
28. Radomska HS, Basseres DS, Zheng R, Zhang P, Dayaram T, et al. (2006) Block of C/EBP alpha function by phosphorylation in acute myeloid leukemia with FLT3 activating mutations. The Journal of experimental medicine 203: 371-381.
29. Hirai H, Zhang P, Dayaram T, Hetherington CJ, Mizuno S, et al. (2006) C/EBPbeta is required for 'emergency' granulopoiesis. Nat Immunol 7: 732-739.